Complete Filing Data
Wearable Devices Ltd. reported Stockholders Equity of $18.55 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Wearable Devices Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Selling And Marketing Expense | $1.9M | $2.1M | $2.0M | $1.4M | $665.0K | $287.0K |
| Revenues | $647.0K | $522.0K | $82.0K | $45.0K | $142.0K | $57.0K |
| Operating Income Loss | -$8.3M | -$7.8M | -$8.2M | -$6.5M | -$2.7M | -$1.2M |
| Net Income Loss | -$8.1M | -$7.9M | -$7.8M | -$6.5M | -$2.6M | -$1.3M |
| General And Administrative Expense | $2.8M | $2.8M | $2.9M | $1.9M | $628.0K | $174.0K |
| Comprehensive Income Net Of Tax | -$8.1M | -$7.9M | -$7.8M | -$6.5M | -$2.6M | -$1.3M |
| Research And Development Net | $3.5M | $3.0M | $3.3M | $2.3M | ||
| Research And Development Expense | $3.3M | $2.3M | $1.4M | $743.0K | ||
| Interest Expense And Exchange Rate | $372.0K | -$38.0K | $55.0K | -$102.0K | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$8.1M | -$7.9M | -$7.8M | -$6.5M | ||
| Gross Profit | -$148.0K | $85.0K | $20.0K | $35.0K | ||
| Cost Of Revenue | $437.0K | $62.0K | $10.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $18.6M | $3.9M | $5.5M | $10.0M | $807.0K | -$2.9M | -$1.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.5M | $3.1M | $810.0K | $10.4M | $1.3M | $475.0K | $1.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $3.4M | $2.3M | -$9.6M | $9.1M | $799.0K | -$1.1M | |
| Property Plant And Equipment Net | $67.0K | $130.0K | $194.0K | $68.0K | $43.0K | ||
| Liabilities Current | $1.4M | $2.1M | $1.8M | $1.2M | $638.0K | ||
| Liabilities And Stockholders Equity | $20.0M | $6.0M | $7.6M | $11.2M | $1.4M | ||
| Liabilities | $1.4M | $2.1M | $2.1M | $1.2M | $638.0K | ||
| FIFO Inventory Amount | $778.0K | $1.2M | $1.0M | $6.0K | $11.0K | ||
| Employee Related Liabilities Current | $629.0K | $402.0K | $579.0K | $416.0K | $222.0K | ||
| Decreaseincrease In Governmental Grants Receivables | -$17.0K | -$91.0K | $54.0K | -$8.0K | $11.0K | $51.0K | |
| Common Stock Value | $67.0K | $67.0K | $57.0K | $43.0K | $31.0K | ||
| Cash And Cash Equivalents At Carrying Value | $6.5M | $3.1M | $810.0K | $10.4M | $1.3M | ||
| Assets Noncurrent | $460.0K | $460.0K | $840.0K | $248.0K | $43.0K | ||
| Assets Current | $19.5M | $5.5M | $6.8M | $11.0M | $1.4M | ||
| Assets | $20.0M | $6.0M | $7.6M | $11.2M | $1.4M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$37.2M | -$29.1M | -$21.2M | -$13.4M | -$6.9M | ||
| Accrued Liabilities Current | $333.0K | $392.0K | $190.0K | $145.0K | $47.0K | ||
| Accounts Payable Current | $62.0K | $157.0K | $410.0K | $156.0K | $72.0K | ||
| Operating Lease Right Of Use Asset | $393.0K | $330.0K | $592.0K | $180.0K | |||
| Operating Lease Liability Current | $309.0K | $291.0K | $297.0K | $68.0K | |||
| Operating Lease Liability Noncurrent | $57.0K | $21.0K | $278.0K | $94.0K | |||
| Grants Receivable | $17.0K | $108.0K | $54.0K | $62.0K | |||
| Rightof Use Asset Recognized Against Lease Liability | $337.0K | $644.0K | $229.0K | ||||
| Prepaid Expense And Other Assets Current | $293.0K | $322.0K | $757.0K | $543.0K | |||
| Increase In Other Receivables And Prepaid Expenses | $136.0K | $496.0K | $30.0K | $11.0K | |||
| Deposits Assets Current | $11.9M | $862.0K | $4.0M | ||||
| Decrease Increase In Other Receivables And Prepaid Expenses | -$21.0K | -$357.0K | $136.0K | $496.0K | |||
| Accrued Interest On Deposits | $150.0K | $3.0K | $45.0K | ||||
| Additional Paid In Capital Common Stock | $55.7M | $32.9M | $26.7M | ||||
| Inventory Write Down | $201.0K | $75.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $1.1M | $182.0K | $241.0K | $790.0K | $299.0K | $67.0K |
| Payments To Acquire Property Plant And Equipment | $20.0K | $43.0K | $194.0K | $48.0K | $36.0K | $16.0K |
| Net Cash Provided By Used In Operating Activities | -$6.6M | -$7.6M | -$8.4M | -$5.7M | -$2.1M | -$1.1M |
| Net Cash Provided By Used In Investing Activities | -$10.9M | $3.2M | -$4.2M | -$66.0K | -$36.0K | -$16.0K |
| Increase Decrease In Inventories | -$247.0K | $269.0K | $1.0M | -$5.0K | -$9.0K | $12.0K |
| Increase Decrease In Employee Related Liabilities | $226.0K | -$177.0K | $163.0K | $194.0K | $119.0K | -$72.0K |
| Increase Decrease In Accrued Liabilities | -$59.0K | $212.0K | $36.0K | $99.0K | $32.0K | -$30.0K |
| Increase Decrease In Accounts Payable | -$95.0K | -$253.0K | $254.0K | $84.0K | $40.0K | -$41.0K |
| Net Cash Provided By Used In Financing Activities | $20.9M | $6.7M | $3.1M | $14.9M | $2.9M | |
| Increase Decrease In Advance Payments | -$37.0K | -$228.0K | -$41.0K | $79.0K | $63.0K | |
| Proceeds From Issuance Of Ordinary Shares As A Result Of Exercise Of Warrants | 1.4M | 160.0K | ||||
| Increase Decrease In Deferred Revenue | -$12.0K | -$12.0K | $9.0K | $4.0K | ||
| Increase Decrease In Accounts Receivable | $37.0K | -$8.0K | $8.0K | |||
| Proceeds From Issuance Of SAF Es | $500.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 1.2M | 108.6K | 67.5K | 153.5K | 9.7M | 6.5M |
| Weighted Average Number Of Diluted Shares Outstanding | 1.2M | 108.6K | 67.5K | 153.5K | 9.7M | 6.5M |
| Earnings Per Share Diluted | $-6.53 | $-72.60 | $-115.20 | $-42.40 | $-0.27 | $-0.19 |
| Earnings Per Share Basic | $-6.53 | $-72.60 | $-115.20 | $-42.40 | $-0.27 | $-0.19 |
| Common Stock Shares Issued | 2.9M | 235.8K | 254.8K | 15.0M | 11.1M | |
| Common Stock Shares Authorized | 500.0M | 50.0M | 50.0M | 50.0M | 20.0M | |
| Common Stock Shares Outstanding | 2.9M | 235.8K | 254.8K | 15.0M | 11.1M | |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | |||
| Proceeds From Issuance Of Shares Issued In The Public Offering Net Of Issuance Cost | 13.3M | 1.6M | 1.7M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Depreciation | $84.0K | $107.0K | $68.0K | $23.0K | $11.0K | $7.0K |
| Cost Direct Material | $594.0K | $362.0K | $62.0K | $10.0K | $10.0K | $9.0K |
| Interest Received From Deposits | -$134.0K | -$144.0K | -$305.0K | |||
| Advance From Customers | $83.0K | $312.0K | $353.0K | $273.0K | ||
| Additional Paid In Capital | $26.7M | $23.3M | $7.7M | |||
| Foreign Currency Transaction Gain Loss Unrealized | -$68.0K | $68.0K | ||||
| Financing Income Net | $230.0K | -$52.0K | $372.0K | |||
| Prospective Initial Public Offering Expenses | $904.0K | $97.0K | ||||
| Advance Payments | $47.0K | $83.0K | ||||
| Interest Paid Net | $49.0K | $40.0K | ||||
| Increase In Advance Payments | $79.0K | $63.0K | $210.0K | |||
| Decrease Increase In Deposits Net | $10.9M | -$3.2M | $4.1M | |||
| Stock Issued During Period Value Stock Options Exercised | $1.0K | |||||
| Stock Issued During Period Value Associated With The SEPA | $4.4M | |||||
| Stock Issued During Period Shares New Issues | 63.0K | 55.6K | ||||
| Stock Issued During Period Shares Exercise Of Warrants | 64.5K | 9.1K | 500.00 |
Most recent annual filing with the SEC: March 12, 2026
Data sourced from SEC EDGAR public filings as of August 8, 2026.